IP Library Granted Patent US 8,671,937
Granted Patent B2
US 8,671,937 · App. 13/421,529 · Granted Mar 18, 2014

Unit dose capsules and dry powder inhaler

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,671,937
App. No.
13/421,529
Granted
Mar 18, 2014
Kind
B2
Abstract

Described is a dry powder inhaler comprising an intake section; a mixing section, and a mouthpiece.

Claims (17)

1. A capsule for a dry powder inhaler comprising:

a first keying surface on a top half of the capsule and a second keying surface on a bottom half of the capsule, wherein the top half and bottom half comprise an outer surface and one or more protrusions to lock and/or unlock the capsule;

an air input hole, and a tangential airflow exit hole;

said capsule having a substantially cylindrical interior shape when the top half and bottom half of the capsule are fitted together;

wherein in an unlocked capsule a hole in the surface of the top half aligns with a hole in the bottom half to direct airflow into the capsule.

2. The capsule according to claim 1 wherein the first keying surface and the second keying surface are the same.

3. The capsule according to claim 1 wherein the first keying surface and the second keying surface are different.

4. The capsule according to claim 1 wherein the second keying surface compliments a movable keying surface on an inhaler.

5. The capsule according to claim 4 wherein the movable keying surface is associated with a joint.

6. The capsule according to claim 1 wherein the air input has a ratio of long axis to short axis of between about 2:1 and about 3:1.

7. The capsule according to claim 6 wherein the ratio is about 3:1.

8. The capsule according to claim 1 wherein the tangential airflow exit leads directly into a mouthpiece of an inhaler.

9. The capsule according to claim 1 wherein the second keying surface is rectangular.

10. The capsule according to claim 1 wherein the first keying surface is triangular.

11. The capsule according to claim 1 further comprising a medicament.

12. The capsule according to claim 11 wherein the medicament is a gel, liquid or dry powder.

13. The capsule according to claim 12 wherein the medicament is a dry powder.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Apr 5, 2024
From: MIDCAP FINANCIAL TRUST, AS AGENT
To: MANNKIND CORPORATION; MANNKIND LLC
Reel/Frame 067024/0082 →
RELEASE OF SECURITY INTEREST Recorded Aug 13, 2019
From: DEERFIELD PRIVATE DESIGN FUND II, L.P.; DEERFIELD PRIVATE DESIGN INTERNATIONAL II, L.P.; HORIZON SANTE FLML SARL
To: MANNKIND CORPORATION
Reel/Frame 050044/0138 →
SECURITY INTEREST Recorded Aug 13, 2019
From: MANNKIND CORPORATION; MANNKIND LLC
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 050044/0181 →
RELEASE OF SECURITY INTEREST Recorded Nov 10, 2016
From: AVENTISUB LLC
To: MANNKIND CORPORATION
Reel/Frame 040588/0008 →
PATENT SECURITY AGREEMENT Recorded Sep 26, 2014
From: MANNKIND CORPORATION
To: AVENTISUB LLC
Reel/Frame 033831/0110 →
SECURITY AGREEMENT Recorded Jul 3, 2013
From: MANNKIND CORPORATION
To: DEERFIELD PRIVATE DESIGN FUND II, L.P.; DEERFIELD PRIVATE DESIGN INTERNATIONAL II, L.P.; HORIZON SANTE FLML SARL
Reel/Frame 030740/0123 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 15, 2012
From: STEINER, SOLOMON S.; FELDSTEIN, ROBERT; FOG, PER B.; POOLE, TRENT
To: PHARMACEUTICAL DISCOVERY CORPORATION
Reel/Frame 027872/0131 →
CHANGE OF NAME Recorded Mar 15, 2012
From: PHARMACEUTICAL DISCOVERY CORPORATION
To: MANNKIND CORPORATION
Reel/Frame 027872/0182 →